| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | Sep 18, 2024 | Direct |
| TScan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 67K | Jun 30, 2025 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Stock Option (right to buy Common Stock) | 32.3K | Nov 6, 2025 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Deferred Restricted Stock Unit (RSU) | 15K | Jun 2, 2025 | Direct | ||
| NextCure, Inc. | Director | Stock Option (Right to Buy) | 14.3K | Jun 22, 2023 | Direct | ||
| G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Sep 18, 2024 | Direct | ||
| Turning Point Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Aug 17, 2022 | Direct |